Brief: Schrodinger Reports Data Showing SGR-1505 Is Well-Tolerated And Achieves Target Engagement In Phase 1 Healthy Volunteer Study

Schrodinger

14/12/2023 12:06

Dec 14 (Reuters) - Schrodinger Inc  SDGR.O :
    * SCHRODINGER - REPORTS DATA SHOWING SGR-1505 IS
WELL-TOLERATED
AND ACHIEVES TARGET ENGAGEMENT IN PHASE 1 HEALTHY VOLUNTEER
STUDY
    * SCHRODINGER - SGR-1505 PROGRESSING WELL, AND WE LOOK
FORWARD TO
CONTINUED ENROLLMENT IN PATIENT STUDY AND REPORTING INITIAL DATA
IN LATE 2024 OR 2025

Source text for Eikon:  ID:nBw4bmXfa 
Further company coverage:  SDGR.O 

 ((Reuters.Briefs@thomsonreuters.com;))